Merck KGaA (FRA:MRK) received a €101.00 ($110.99) price objective from equities researchers at Commerzbank AG in a report issued on Thursday. The brokerage presently has a a “buy” rating on the stock.

Several other equities research analysts have also recently weighed in on the stock. DZ Bank AG reiterated a “buy” rating on shares of Merck KGaA in a research report on Monday, October 24th. Societe Generale set a €97.00 ($106.59) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Monday, October 17th. Goldman Sachs Group Inc. set a €99.00 ($108.79) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Monday, October 17th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Merck KGaA in a research report on Friday, October 14th. Finally, Bankhaus Lampe set a €112.00 ($123.08) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a research report on Friday, October 14th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €101.50 ($111.54).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) opened at 95.879 on Thursday. The firm has a market capitalization of €41.69 billion and a price-to-earnings ratio of 30.000. The stock’s 50 day moving average is €95.82 and its 200 day moving average is €92.56. Merck KGaA has a 1-year low of €70.87 and a 1-year high of €100.00.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.